Stock·NYSE·Consumer Cyclical
D.R. Horton, Inc. (DHI)
- Market cap
- $41.12B
- P/E
- 14.02
- Dividend yield
- 1.22%
- Street target
- $150.00median of 21 analysts
- 52-week range
- $130.40 $170.79
DHI stock forecast today
Where DHI stands today, and what CleaRank Financial AI makes of it.
DHI at a glance
D.R. Horton, Inc. (DHI): Buy, 75/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 50-day but below its 200-day moving average ($141.00 and $147.81).
- Earnings DHI beat estimates in 5 of its last 8 quarters, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $6.4M and made no open-market purchases over the last 18 months.
- Valuation P/E of 14.0 against 20.8 for the Consumer Cyclical sector: a discount to peers (-33%).
Figures as of October 27, 2026.
CleaRank Financial AI
D.R. Horton, Inc. (DHI) earns a CleaRank rating of Buy and a model score of 75/100.
The biggest lift to that score comes from valuation, with a P/E of 14.02 that is 32.6% below the sector median (a discount to peers) and a P/S of 1.23 that is 35.3% below the sector median. The trend is mixed. DHI sits 4.27% above its 50-day average of $141.00 but 0.53% below its 200-day average of $147.81. The price has fallen 7.45% over the past year.
Only on CleaRank
Figures we compute ourselves from DHI's own price, earnings and insider-filing history. Tap one to see it in context.
DHI stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
1/4Price above its 50-day average ›
The price of $147.02 is 4.3% above the 50-day simple moving average of $141.00.Price above its 200-day average ›
The price is 0.5% below the 200-day simple moving average of $147.81.50-day average above the 200-day ›
The 50-day average ($141.00) is 4.6% below the 200-day average ($147.81), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 41% of its 52-week range, between $130.40 and $170.79.
DHI share price
Pick a period: each tab shows how far DHI has moved over it, to the last close.
Today's trading
Where DHI sits inside today's range and its 52-week range.
DHI fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 14.02 is 32.6% below the Consumer Cyclical median of 20.8.P/S below the sector median ›
The price-to-sales ratio of 1.23 is 35.1% below the sector median of 1.9.Profitable over the last 12 months ›
Net income over the last 12 months was $3.1B on revenue of $33.4B, a net margin of 9.2%.Beat estimates in most recent reports ›
DHI beat the EPS estimate in 5 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 1.22%, or $1.80 a share a year.
Key statistics
The headline figures for DHI.
As of October 27, 2026, DHI trades at $147.02, with a market value of $41.12B, a P/E ratio of 14.02 and a dividend yield of 1.22%.
What the numbers say
CleaRank Financial AI's reading of DHI's valuation, growth and risks.
D.R. Horton, Inc. (DHI) trades on a P/E of 14.02, which is 32.6% below the Consumer Cyclical sector median of 20.8. That gap places it at a discount to peers. Measured against sales, its P/S of 1.23 sits 35.3% below the sector median of 1.9. Its market value of $41.1B gives a sense of its overall size.
Margins stand at a net margin of 9.15% and an operating margin of 12.99%. It generates a return on equity of 12.63%, above the sector median of 12.4%. Debt-to-equity of 0.29 and a trailing dividend yield of 1.22% ($1.80 a share a year) round out the fundamentals.
The July 21, 2026 report beat expectations by 7.02%: $3.20 a share against a $2.99 estimate. Even so, the share price fell 0.70% in the first session after the report.
DHI beat the EPS estimate in 5 of its last 8 reports, yet the share price fell in the next session after 3 of those 5 beats. Forward estimates point in two directions: analysts expect EPS of $10.43 for this fiscal year, a decline of 9.9%, and $11.15 for the year after, growth of 6.9%.
DHI moves an average of 2.17% a day, and its beta against the S&P 500 is 1.35. Insiders sold $6.4M of stock over the last 18 months and made no open-market purchases. Sales made under pre-arranged plans, or to cover taxes on vesting shares, carry less weight than purchases, so the selling is a softer signal.
DHI against the Consumer Cyclical sector
How DHI compares with the median Consumer Cyclical stock CleaRank tracks.
Price to earnings vs sector: DHI trades at a notable discount to sector peers (-33%), which may indicate undervaluation or specific company headwinds.
Return vs SPY: Since May 15, 2025, DHI has gained 19.2% against a gain of 30.4% for SPY.
Performance against SPY
DHI and the S&P 500 (SPY) over the same days.
Revenue and earnings
How much DHI sells, and how much of it becomes profit.
Revenue growth: Revenue fell 6.9% in FY2025 to $34.3B, from $36.8B a year earlier.
Profit margin: The net margin was 10.6% in FY2025, down from 13.1% the year before.
Profitable: DHI earned $3.6B in FY2025.
Earnings reality check
Did DHI beat what analysts expected, and how did the stock react?
Earnings record: DHI beat the analyst estimate in 5 of the last 8 quarters.
Market reaction: The stock fell in the first session after 3 of those 5 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 21, 2026after close | $2.99 | $3.20 | +7.02% | -0.70% | +5.32% |
| Apr 21, 2026after close | $2.14 | $2.24 | +4.67% | -0.63% | -3.57% |
| Jan 20, 2026after close | $1.92 | $2.03 | +5.73% | +3.21% | -3.00% |
| Oct 28, 2025after close | $3.27 | $3.04 | -7.03% | -3.55% | -5.31% |
| Jul 22, 2025after close | $2.90 | $3.36 | +15.86% | -3.47% | -4.01% |
| Apr 17, 2025after close | $2.65 | $2.58 | -2.64% | -0.40% | +2.73% |
| Jan 21, 2025after close | $2.37 | $2.61 | +10.13% | +2.25% | +0.17% |
| Oct 29, 2024after close | $4.16 | $3.92 | -5.77% | +1.18% | +3.56% |
As of October 27, 2026, DHI has beaten the analyst EPS estimate in 5 of its last 8 reported quarters and fell in the first trading session after 3 of those beats; its latest report, on July 21, 2026, came in 7.02% above the estimate and the stock moved -0.70% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
DHI AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 60.7, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 60.7 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of DHI
The score, the reasoning behind it, and what could move the price next.
DHI is trading at $147.02, caught between its two moving averages. The price is 0.53% below the 200-day average of $147.81 but 4.27% above the 50-day average of $141.00. Across the 52-week range, which spans $130.40 to $170.79, the current price stands at 41% of the distance from the low.
Recent gains sit against a weaker longer record: the price rose 3.89% over the past month, fell 2.74% over the past three months and fell 7.45% over the past year. On momentum, the 14-day RSI reads 60.7, in the bullish zone, below the overbought line, with the MACD line positive. The price rose 0.34% in the last session on volume 31.8% below its average.
New analyst coverage ›
Melius Research started coverage at Sell on October 6, 2026.
Source: Analyst action, Melius Research, October 6, 2026
Earnings beat, but the stock fell ›
The July 21, 2026 report beat the EPS estimate by 7.02%, and the share price fell 0.70% in the first session after it.
Source: Earnings report, July 21, 2026New analyst coverage ›
StoneX started coverage at Hold on October 16, 2026.
Source: Analyst action, StoneX, October 16, 2026
- Keep an eye on the two closest levels: the 200-day SMA at $147.81 sits above the price, and the 50-day SMA at $141.00 sits below it.
- The 14-day RSI reads 60.7, in the bullish zone, with the MACD line positive; readings above 70 or below 30 mark stretched momentum.
- The share price fell 0.70% in the first session after the July 21, 2026 report. Across the last 8 reports, DHI beat estimates in 5.
DHI sends mixed trend signals. The price is above its 50-day average of $141.00 but below its 200-day average of $147.81. A close above the 200-day would bring both signals up, while a close below the 50-day would bring both down. For now the price is wedged between the 50-day SMA at $141.00 underneath and the 200-day SMA at $147.81 overhead.
The RSI sits in the bullish band, which supports the current direction without being stretched.
Technical indicators
Momentum and trend for DHI, from its daily closes.
As of October 27, 2026, with DHI at $147.02, its 14-day RSI is 60.7 (showing bullish momentum without being overbought), its 50-day simple moving average is $141.00 and its 200-day is $147.81.
Calculated by CleaRank on daily closes as of October 27, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What DHI moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 27, 2026, DHI's 1-year correlation of daily returns is +0.28 with S&P 500 (SPY), +0.17 with Nasdaq 100 (QQQ), +0.02 with Bitcoin (BTC) and +0.11 with gold (XAU).
DHI price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
1/3Most analysts rate it a buy ›
4 of 21 analysts rate it a buy or strong buy, 15 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $150.00 is 2.0% above the price.More buy ratings than three months ago ›
4 of 21 rate it a buy now, against 4 of 18 three months ago.
DHI Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 16, 2026 | Wells Fargo | Maintains | Equal-Weight |
| Oct 16, 2026 | StoneX | Initiates | Hold |
| Oct 15, 2026 | Citigroup | Maintains | Neutral |
| Oct 15, 2026 | RBC Capital | Maintains | Underperform |
| Oct 6, 2026 | Melius Research | Initiates | Sell |
| Oct 6, 2026 | Barclays | Maintains | Equal-Weight |
As of October 27, 2026, 21 Wall Street analysts cover DHI: 4 rate it a buy or strong buy, 15 a hold and 2 a sell or strong sell. Their 12-month price targets range from $119.00 to $206.00. The median DHI price target is $150.00, 2.0% above the price of $147.02.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
DHI trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
DHI trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from DHI's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much DHI tends to move, against the market and on its own.
DHI price history and drawdowns
DHI's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 2.17% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 53.5%, from February 2020 to March 2020, regained by July 2020.Most 1-year holds ended higher ›
70% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $57,406, against $42,376 in the S&P 500 (SPY).
DHI Drawdowns & Recovery
As of October 27, 2026, DHI's worst peak-to-trough fall over the last 10 years with dividends reinvested was -53.5% (February 2020 to March 2020); it regained that peak by July 2020, 4 months after the low, and 70% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into DHI in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: DHI beat the S&P 500 over this period: $57,406 against $42,376.
A $10,000 investment in DHI in October 2016 would be worth about $57,406 today with dividends reinvested, compared with about $42,376 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to DHI, and which have not.
Strongest month, July: an average of +9.96%, up in 9 of 10 years.
Weakest month, September: an average of -2.01%, up in 5 of 10 years.
This month, October: has averaged -1.15%, up in 3 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, DHI's strongest calendar month has been July (average +9.96%, up in 9 of 10 years) and its weakest September (average -2.01%, up in 5 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
DHI stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in DHI, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in DHI today could grow to about $14,559 by 2030 in the base case, with a 90th-percentile outcome near $36,853 and a 10th-percentile outcome around $5,752. The simulation models price only; at today's 1.22% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
DHI Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $214 for DHI by 2030 in the base case, from $147 today (1.5x over 4 years). The 10th-percentile path ends near $84.56. These are outcomes of a Monte Carlo simulation run on DHI's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $102 | $161 | $257 | |
| 2028 | $91.99 | $177 | $342 | |
| 2029 | $87.18 | $195 | $436 | |
| 2030 | $84.56 | $214 | $542 |
Method: a lognormal simulation of DHI's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
DHI insider trading
What the people running the company have bought and sold.
DHI insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought DHI shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 27, 2026, DHI insiders reported 6 open-market sales worth $6.4M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 8, 2026 | Michael John Murray
Chief Operating Officer
|
Grant | 5.0K | - |
| Aug 26, 2026 | Elaine D Crowley
Director
|
Grant | 264 | - |
| Aug 26, 2026 | Michael Chad Crow
Director
|
Grant | 264 | - |
| Aug 26, 2026 | Barbara R Smith
Director
|
Grant | 264 | - |
| Apr 22, 2026 | David V Auld
Officer and Director
|
Grant | 5.1K | - |
| Apr 22, 2026 | Michael John Murray
Chief Operating Officer
|
Grant | 6.4K | - |
| Apr 22, 2026 | Paul J. Romanowski
Chief Executive Officer
|
Grant | 7.7K | - |
| Apr 22, 2026 | Bill W Wheat
Chief Financial Officer
|
Grant | 5.1K | - |
| Apr 20, 2026 | Bradley S Anderson
Director
|
Grant | 139 | - |
| Apr 20, 2026 | David V Auld
Officer and Director
|
Grant | 7.0K | - |
| Apr 20, 2026 | Benjamin S Carson Sr
Director
|
Grant | 683 | - |
| Apr 20, 2026 | Maribess L Miller
Director
|
Grant | 139 | - |
| Apr 20, 2026 | Michael John Murray
Chief Operating Officer
|
Grant | 2.4K | - |
| Apr 20, 2026 | Paul J. Romanowski
Chief Executive Officer
|
Grant | 2.4K | - |
| Apr 20, 2026 | Bill W Wheat
Chief Financial Officer
|
Grant | 1.6K | - |
| Mar 30, 2026 | Bradley S Anderson
Director
|
Grant | 224 | - |
| Mar 30, 2026 | Benjamin S Carson Sr
Director
|
Grant | 224 | - |
| Mar 30, 2026 | Maribess L Miller
Director
|
Grant | 224 | - |
| Mar 30, 2026 | Aron M Odom
Officer
|
Grant | 887 | - |
| Mar 30, 2026 | Bill W Wheat
Chief Financial Officer
|
Grant | 2.5K | - |
| Mar 23, 2026 | Michael John Murray
Chief Operating Officer
|
Grant | 3.8K | - |
| Mar 23, 2026 | Paul J. Romanowski
Chief Executive Officer
|
Grant | 3.8K | - |
| Mar 20, 2026 | Bradley S Anderson
Director
|
Grant | 93 | - |
| Mar 20, 2026 | Benjamin S Carson Sr
Director
|
Grant | 93 | - |
| Mar 20, 2026 | Maribess L Miller
Director
|
Grant | 93 | - |
| Mar 20, 2026 | Aron M Odom
Officer
|
Grant | 1.1K | - |
| Mar 17, 2026 | Bradley S Anderson
Director
|
Grant | 203 | - |
| Mar 17, 2026 | Maribess L Miller
Director
|
Grant | 203 | - |
| Mar 17, 2026 | Michael John Murray
Chief Operating Officer
|
Grant | 2.2K | - |
| Mar 17, 2026 | Aron M Odom
Officer
|
Grant | 764 | - |
| Mar 17, 2026 | Paul J. Romanowski
Chief Executive Officer
|
Grant | 1.7K | - |
| Mar 17, 2026 | Bill W Wheat
Chief Financial Officer
|
Grant | 2.2K | - |
| Feb 13, 2026 | Aron M Odom
Officer
|
Sell | 260 | $43.6K |
| Jan 21, 2026 | Michael John Murray
Chief Operating Officer
|
Grant | 7.1K | - |
| Dec 15, 2025 | David V Auld
Officer and Director
|
Grant | 10.0K | - |
| Dec 11, 2025 | Paul J. Romanowski
Chief Executive Officer
|
Grant | 3.3K | - |
| Dec 1, 2025 | David V Auld
Officer and Director
|
Grant | 1.5K | - |
| Nov 20, 2025 | Bradley S Anderson
Director
|
Grant | 289 | - |
| Nov 20, 2025 | David V Auld
Officer and Director
|
Grant | 12.3K | - |
| Nov 20, 2025 | Michael R Buchanan
Director
|
Grant | 289 | - |
| Nov 20, 2025 | Benjamin S Carson Sr
Director
|
Grant | 289 | - |
| Nov 20, 2025 | Elaine D Crowley
Director
|
Grant | 289 | - |
| Nov 20, 2025 | Michael Chad Crow
Director
|
Grant | 289 | - |
| Nov 20, 2025 | Maribess L Miller
Director
|
Grant | 289 | - |
| Nov 20, 2025 | Michael John Murray
Chief Operating Officer
|
Grant | 1.6K | - |
| Nov 20, 2025 | Aron M Odom
Officer
|
Grant | 430 | - |
| Nov 20, 2025 | Paul J. Romanowski
Chief Executive Officer
|
Grant | 1.6K | - |
| Nov 20, 2025 | Barbara R Smith
Director
|
Grant | 289 | - |
| Nov 20, 2025 | Bill W Wheat
Chief Financial Officer
|
Grant | 1.4K | - |
| Nov 7, 2025 | David V Auld
Officer and Director
|
Grant | 7.0K | - |
| Nov 7, 2025 | Michael John Murray
Chief Operating Officer
|
Grant | 2.1K | - |
| Nov 7, 2025 | Paul J. Romanowski
Chief Executive Officer
|
Grant | 2.1K | - |
| Nov 7, 2025 | Bill W Wheat
Chief Financial Officer
|
Grant | 1.9K | - |
| Oct 29, 2025 | David V Auld
Officer and Director
|
Grant | 191.7K | - |
| Oct 29, 2025 | David V Auld
Officer and Director
|
Grant | 8.5K | - |
| Oct 29, 2025 | Michael John Murray
Chief Operating Officer
|
Grant | 71.9K | - |
| Oct 29, 2025 | Michael John Murray
Chief Operating Officer
|
Grant | 10.6K | - |
| Oct 29, 2025 | Paul J. Romanowski
Chief Executive Officer
|
Grant | 12.7K | - |
| Oct 29, 2025 | Paul J. Romanowski
Chief Executive Officer
|
Grant | 71.9K | - |
| Oct 29, 2025 | Bill W Wheat
Chief Financial Officer
|
Grant | 8.5K | - |
| Oct 29, 2025 | Bill W Wheat
Chief Financial Officer
|
Grant | 47.9K | - |
| Sep 9, 2025 | Michael John Murray
Chief Operating Officer
|
Grant | 3.0K | - |
| Sep 5, 2025 | David V Auld
Officer and Director
|
Sell | 30.0K | $5.5M |
| Sep 5, 2025 | Aron M Odom
Officer
|
Sell | 1.4K | $251.8K |
| Sep 5, 2025 | Michael R Buchanan
Director
|
Sell | 1.0K | $180.7K |
| Sep 5, 2025 | David V Auld
Officer and Director
|
Grant | 20.0K | - |
| Aug 27, 2025 | Michael John Murray
Chief Operating Officer
|
Grant | 5.5K | - |
| Aug 26, 2025 | Elaine D Crowley
Director
|
Grant | 264 | - |
| Aug 26, 2025 | Michael Chad Crow
Director
|
Grant | 264 | - |
| Aug 26, 2025 | Barbara R Smith
Director
|
Grant | 264 | - |
| Aug 13, 2025 | Aron M Odom
Officer
|
Sell | 1.2K | $204.9K |
| Aug 6, 2025 | David V Auld
Officer and Director
|
Grant | 25.0K | - |
| Jun 24, 2025 | Michael R Buchanan
Director
|
Sell | 2.2K | $274.6K |
Source: TwelveData, from SEC Form 4 filings
DHI stock forecast: questions people ask
Answered from the figures on this page, as of October 27, 2026.